Literature DB >> 27981344

[Characteristics of elective hip replacement in the elderly].

T Claßen1, C Scheid1, S Landgraeber1, M Jäger2.   

Abstract

Due to demographic changes the number of elderly patients undergoing hip replacement surgery is increasing. In order to ensure safe treatment of elderly patients, age-specific medical factors must be taken into consideration. This article presents an overview of these factors. Furthermore, we evaluated our own patients treated between 2010 and 2015 regarding age-related treatment strategies and complication rates. Out of 3166 patients a total of 439 were over 80 years old (average age 84 years). It can be concluded from the scientific literature and from own data that elective hip replacement surgery in elderly patients is a technically safe procedure; however, the risk profile of each patient must be thoroughly analyzed so that in the event of even minor signs of potential complications countermeasures can be taken in good time.

Entities:  

Keywords:  Indications; Mobility; Reintegration; Risk factors; Total hip replacement

Mesh:

Year:  2017        PMID: 27981344     DOI: 10.1007/s00132-016-3364-4

Source DB:  PubMed          Journal:  Orthopade        ISSN: 0085-4530            Impact factor:   1.087


  55 in total

1.  Preoperative asymptomatic leucocyturia and early prosthetic joint infections in patients undergoing joint arthroplasty.

Authors:  Wenlong Gou; Jiying Chen; Yanhui Jia; Yan Wang
Journal:  J Arthroplasty       Date:  2013-08-29       Impact factor: 4.757

2.  Psychiatric Disorders and Psychopharmacologic Treatment as Risk Factors in Elective Fast-track Total Hip and Knee Arthroplasty.

Authors:  Christoffer C Jørgensen; Joachim Knop; Merete Nordentoft; Henrik Kehlet
Journal:  Anesthesiology       Date:  2015-12       Impact factor: 7.892

Review 3.  10-year experience with short stem total hip arthroplasty.

Authors:  Gabriela von Lewinski; Thilo Floerkemeier
Journal:  Orthopedics       Date:  2015-03       Impact factor: 1.390

Review 4.  Risk factors for venous thromboembolism after total hip and total knee arthroplasty: a meta-analysis.

Authors:  Jie Zhang; Zhihao Chen; Jilin Zheng; Steffen J Breusch; Jing Tian
Journal:  Arch Orthop Trauma Surg       Date:  2015-04-09       Impact factor: 3.067

Review 5.  Muscle function and fat content in relation to sarcopenia, obesity and frailty of old age--An overview.

Authors:  Assaf Buch; Eli Carmeli; Lital Keinan Boker; Yonit Marcus; Gabi Shefer; Ofer Kis; Yitshal Berner; Naftali Stern
Journal:  Exp Gerontol       Date:  2016-01-16       Impact factor: 4.032

6.  Postoperative Morbidity and Discharge Destinations After Fast-Track Hip and Knee Arthroplasty in Patients Older Than 85 Years.

Authors:  Frederik T Pitter; Christoffer C Jørgensen; Martin Lindberg-Larsen; Henrik Kehlet
Journal:  Anesth Analg       Date:  2016-06       Impact factor: 5.108

7.  A plasma-sprayed titanium proximal coating reduces the risk of periprosthetic femoral fracture in cementless hip arthroplasty.

Authors:  Brad Miles; William L Walter; Elizabeth Kolos; Tim Waters; Richard Appleyard; R Mark Gillies; Shane Donohoo; Andrew J Ruys
Journal:  Biomed Mater Eng       Date:  2015       Impact factor: 1.300

Review 8.  [Obesity in elderly].

Authors:  Monika Lechleitner
Journal:  Wien Med Wochenschr       Date:  2016-01-28

Review 9.  Risk factors for venous thromboembolism of total hip arthroplasty and total knee arthroplasty: a systematic review of evidences in ten years.

Authors:  Zi-hao Zhang; Bin Shen; Jing Yang; Zong-ke Zhou; Peng-de Kang; Fu-xing Pei
Journal:  BMC Musculoskelet Disord       Date:  2015-02-10       Impact factor: 2.362

10.  Patient refusal for regional anesthesia in elderly orthopedic population: A cross-sectional survey at a tertiary care hospital.

Authors:  Asma Abdus Salam; Gauhar Afshan
Journal:  J Anaesthesiol Clin Pharmacol       Date:  2016 Jan-Mar
View more
  1 in total

1.  Total hip arthroplasty in geriatric patients - a single-center experience.

Authors:  Philip Mark Anderson; Peter Vollmann; Manuel Weißenberger; Maximilian Rudert
Journal:  SICOT J       Date:  2022-04-04
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.